Your browser doesn't support javascript.
loading
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population.
Patra, Tapas; Cunningham, David M; Meyer, Keith; Toth, Karoly; Ray, Ratna B; Heczey, Andras; Ray, Ranjit.
Afiliação
  • Patra T; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA. Electronic address: tpatra012@gmail.com.
  • Cunningham DM; Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Meyer K; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA.
  • Toth K; Department of Molecular Microbiology & Immunology and Saint Louis University, St. Louis, MO 63104, USA.
  • Ray RB; Department of Pathology, Saint Louis University, St. Louis, MO 63104, USA.
  • Heczey A; Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Ray R; Department of Internal Medicine, Saint Louis University, St. Louis, MO 63104, USA; Department of Molecular Microbiology & Immunology and Saint Louis University, St. Louis, MO 63104, USA. Electronic address: rayr@slu.edu.
Mol Ther ; 31(3): 715-728, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36609146

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Receptores de Antígenos Quiméricos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Receptores de Antígenos Quiméricos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article